XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

Ethics Channel
subscribe to Ethics newsletter

Special Topics : Ethics

   DISCUSS   |   EMAIL   |   PRINT
Yale guidelines for physician interactions with pharmaceutical industry
Jan 28, 2006 - 12:54:00 PM, Reviewed by: Dr. Priya Saxena

"The Yale guidelines are offered as an example of how one medical school has attempted to meet the challenge of maintaining professionalism, integrity and public service,"

 
To highlight the importance of impeccable financial relationships between the pharmaceutical industry and physicians, the faculty of Yale University School of Medicine has developed and approved some of the most stringent guidelines for the interactions of their faculty with the pharmaceutical industry.

The Yale guidelines are meant to preserve and enhance the critical role academic medical centers play in establishing professional standards. Detailed in the February 2006 issue of Academic Medicine, the guidelines go beyond existing recommendations and ban faculty from receiving any form of gift, meal, or free drug sample (for personal use) from industry, and set more stringent standards for the disclosure and resolution of financial conflict of interest in Yale's educational programs.

"The overriding goal of the guidelines is to ensure that the integrity of clinical decision making is not compromised by financial or other personal relationships with industry," said lead author David L. Coleman, M.D., professor and interim chair of Internal Medicine at Yale School of Medicine. Coleman would like the guidelines to promote an effective and ethical partnership between medical schools and the pharmaceutical industry.

The guidelines were developed and refined with extensive faculty input over a 12-month period. It incorporates the input of representatives from several pharmaceutical companies in formulating the guidelines. The Board of Governors of the Yale Medical Group (YMG), a group practice composed of Yale full-time faculty, approved the guidelines in May 2005.

Coleman acknowledges that guidelines alone will not eliminate conflicts of interest. He said it will be important to continue educating faculty and trainees on how to develop and sustain productive and ethical relationships with commercial entities.

"The Yale guidelines are offered as an example of how one medical school has attempted to meet the challenge of maintaining professionalism, integrity and public service," said Coleman. "We will need to monitor the effect of these and other guidelines to evaluate their effectiveness in reducing conflicts and bias in educational programs."
 

- Academic Medicine, Vol. 81, No. 2 154-160 (February 2006)
 

www.yale.edu

 
Subscribe to Ethics Newsletter
E-mail Address:

 

Other authors on the study were Alan E. Kazdin, Lee Ann Miller, Jon S. Morrow, M.D., and Robert Udelsman, M.D.

Related Ethics News

Waiting For Trial Results Sometimes Unethical
NHGRI Funds Assessment of Public Attitudes About Population-Based Studies on Genes and Environment
Physicians More Likely To Disclose Medical Errors That Would Be Apparent To The Patient
Doctors inadvertently help terminally ill patients to die sooner
Intellectual property law and the protection of traditional knowledge
Conscientious objection in medicine should not be tolerated
Yale guidelines for physician interactions with pharmaceutical industry
Current interpretation of the data protection law is hampering epidemiological research
Massachusetts state can pull plug on comatose 11-year-old girl
Facial Transplants - Are they justified?


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us